SCYX - Why Are Antifungal Focused Scynexis Stock Plunging Today? | Benzinga
Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifungal pill, Brexafemme (ibrexafungerp), from the market and placing a temporary hold on clinical studies of ibrexafungerp, including the Phase 3 MARIO study, until a mitigation strategy and a resupply plan are determined.